View:
Download DOC
Download PDF
Download XLS
SEC FORM 3 SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940 		 
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Wentzel Steven L
(Last) (First) (Middle)
5960 BERKSHIRE LN #800
(Street)
DALLAS TX 75225
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
06/01/2020 		3. Issuer Name and Ticker or Trading Symbol
EAGLE MATERIALS INC [ EXP ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
President (American Gypsum)
 5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 19,750(1) D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Non-Qualified Stock Option (Right to Buy) (2) 06/10/2025 Common Stock 4,038 81.56 D
Non-Qualified Stock Option (Right to Buy) (3) 05/20/2026 Common Stock 6,672 75.69 D
Non-Qualified Stock Option (Right to Buy) (4) 05/20/2026 Common Stock 5,641 75.69 D
Non-Qualified Stock Option (Right to Buy) (5) 05/18/2027 Common Stock 4,726 100.88 D
Non-Qualified Stock Option (Right to Buy) (6) 05/18/2027 Common Stock 4,094 100.88 D
Non-Qualified Stock Option (Right to Buy) (7) 05/17/2028 Common Stock 4,352 106.24 D
Non-Qualified Stock Option (Right to Buy) (8) 05/17/2028 Common Stock 4,042 106.24 D
Non-Qualified Stock Option (Right to Buy) (9) 05/16/2029 Common Stock 5,306 91.58 D
Non-Qualified Stock Option (Right to Buy) (10) 05/16/2029 Common Stock 5,024 91.58 D
Explanation of Responses:
1. This number includes the following restricted shares: (a) 734 shares remaining from a grant awarded to the reporting person on 5/18/2017, the restrictions on which will lapse on 3/31/2021; (b) 1,343 shares remaining from a grant awarded to the reporting person on 5/17/2018, the restrictions on which will lapse ratably on March 31 of 2021 and 2022; (c) 2,315 shares remaining from a grant awarded to the reporting person on 5/16/2019, the restrictions on which will lapse ratably on March 31 of 2021, 2022 and 2023; and (d) 4,983 shares awarded to the reporting person on 5/19/2020, the restrictions on which will lapse ratably on March 31 of 2021, 2022, 2023 and 2024.
2. On June 10, 2015 the reporting person was granted an option to purchase up to 12,116 shares of Common Stock and currently 4,038 of these options remain exercisable.
3. On May 20, 2016, the reporting person was granted an option to purchase up to 6,769 shares of Common Stock subject to the achievement by the Company of certain performance vesting criteria measured at the end of fiscal 2017. On May 10, 2017, the performance conditions were determined to have been satisfied such that stock options vested as to 6,672 shares and currently all of these options are exercisable.
4. On May 20, 2016 the reporting person was granted an option to purchase up to 5,641 shares of Common Stock and currently all of these options are exercisable.
5. On May 18, 2017, the reporting person was granted an option to purchase up to 4,912 shares of Common Stock subject to the achievement by the Company of certain performance vesting criteria measured at the end of fiscal 2018. On May 7, 2018, the performance conditions were determined to have been satisfied such that stock options vested as to 4,726 shares. Currently 3,545 options are exercisable and the remaining 1,181 options become exercisable on March 31, 2021.
6. On May 18, 2017 the reporting person was granted an option to purchase up to 4,094 shares of Common Stock. Currently 3,071 options are exercisable and the remaining 1,023 options become exercisable on March 31, 2021.
7. On May 17, 2018, the reporting person was granted an option to purchase up to 4,851 shares of Common Stock subject to the achievement by the Company of certain performance vesting criteria measured at the end of fiscal 2019. On May 13, 2019, the performance conditions were determined to have been satisfied such that stock options vested as to 4,352 shares. Currently 2,176 options are exercisable and the remaining options vest ratably on March 31 of 2021 and 2022.
8. On May 17, 2018 the reporting person was granted an option to purchase up to 4,042 shares of Common Stock, Currently 2,022 options are exercisable and the remaining options will vest ratably on March 31 of 2021 and 2022.
9. On May 16, 2019, the reporting person was granted an option to purchase up to 6,029 shares of Common Stock subject to the achievement by the Company of certain performance vesting criteria measured at the end of fiscal 2020. On May 4, 2020, the performance conditions were determined to have been satisfied such that stock options vested as to 5,306 shares. Currently 1,327 options are exercisable and the remaining options vest ratably on March 31 of 2021, 2022 and 2023.
10. On May 16, 2019 the reporting person was granted an option to purchase up to 5,024 shares of Common Stock, Currently 1,256 options are exercisable and the remaining options will vest ratably on March 31 of 2021, 2022 and 2023.
Remarks:
/s/ Scott M. Wilson as Attorney-in-Fact for Steven L. Wentzel 06/11/2020
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
LIMITED POWER OF ATTORNEY FOR
SECTION 16 REPORTING OBLIGATIONS
	Know all by these presents, that the undersigned hereby constitutes and
appoints each of
James H. Graass, Scott M. Wilson and Matt Newby, or any of them signing singly,
and with full power of
substitution, the undersigned's true and lawful attorney-in-fact to:
	(1)	execute for and on behalf of the undersigned, in the undersigned's capacity
as an
officer and/or director of Eagle Materials Inc., a Delaware corporation (the
"Company"), (a) Forms 3, 4,
and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934
and the rules thereunder;
and (b) Form 144;
	(2)	do and perform any and all acts for and on behalf of the undersigned which
may be
necessary or desirable to complete and execute any such Form 3, 4 or 5, or Form
144, complete and
execute any amendment or amendments thereto, and timely file such form with the
SEC and any stock
exchange or similar authority; and
	(3)	take any other action of any type whatsoever in connection with the
foregoing which,
in the opinion of such attorney-in-fact, may be of benefit to, in the best
interest of, or legally required by,
the undersigned, it being understood that the documents executed by such
attorney-in-fact on behalf of the
undersigned pursuant to this Limited Power of Attorney shall be in such form and
shall contain such
terms and conditions as such attorney-in-fact may approve in such
attorney-in-fact's discretion.
	The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and
perform any and every act and thing whatsoever requisite, necessary, or proper
to be done in the exercise
of any of the rights and powers herein granted, as fully to all intents and
purposes as the undersigned
might or could do if personally present, with full power of substitution or
revocation, hereby ratifying and
confirming all that such attorney-in-fact, or such attorney-in-fact's substitute
or substitutes, shall lawfully
do or cause to be done by virtue of this Limited Power of Attorney and the
rights and powers herein
granted.  The undersigned acknowledges that the foregoing attorneys-in-fact, in
serving in such capacity
at the request of the undersigned, are not assuming, nor is the Company
assuming, any of the
undersigned's responsibilities to comply with Section 16 of the Securities
Exchange Act of 1934.
	This Limited Power of Attorney supersedes any Section 16 power of attorney
previously granted
by the undersigned with respect to the undersigned's holdings of and
transactions in securities issued by
the Company and shall remain in full force and effect until the undersigned is
no longer required to file
Forms 3, 4, and 5 and Form 144 with respect to the undersigned's holdings of and
transactions in
securities issued by the Company, unless earlier revoked by the undersigned in a
signed writing delivered
to the foregoing attorneys-in-fact.
	IN WITNESS WHEREOF, the undersigned has caused this Limited Power of Attorney
to be
executed as of this 8th day of June, 2020.

					    /s/ Steven L. Wentzel
					Steven L. Wentzel



L:\SEC\Power of Attorney\Section 16 POA (2020) - Wentzel.docx